Advertisement
Screener

SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Form 6-K: Report of foreign private issuer, 2023

SCINAI IMMUNOTHERAPEUTICS LTD. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2023-12-14: Form 6-K; Period of report 2023-12-14; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea190037-6k_scinaiimmun.htm.
  • 2023-11-20: Form 6-K; Period of report 2023-11-20; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea188732-6k_scinaiimmun.htm.
  • 2023-11-13: Form 6-K; Period of report 2023-11-13; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea188213-6k_scinaiimmun.htm.
  • 2023-11-07: Form 6-K; Period of report 2023-11-07; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea187771-6k_scinaiimmun.htm.
FiledFormPeriod of reportDescriptionDocument
2023-12-146-K2023-12-14REPORT OF FOREIGN PRIVATE ISSUERea190037-6k_scinaiimmun.htm
2023-11-206-K2023-11-20REPORT OF FOREIGN PRIVATE ISSUERea188732-6k_scinaiimmun.htm
2023-11-136-K2023-11-13REPORT OF FOREIGN PRIVATE ISSUERea188213-6k_scinaiimmun.htm
2023-11-076-K2023-11-07REPORT OF FOREIGN PRIVATE ISSUERea187771-6k_scinaiimmun.htm
2023-11-036-K2023-11-03REPORT OF FOREIGN PRIVATE ISSUERea187705-6k_scinaiimmun.htm
2023-11-026-K2023-11-02REPORT OF FOREIGN PRIVATE ISSUERea187657-6k_scinaiimmun.htm
2023-09-226-K2023-09-22REPORT OF FOREIGN PRIVATE ISSUERea185649-6k_scinaiimmu.htm
2023-09-206-K2023-09-20REPORT OF FOREIGN PRIVATE ISSUERea185474-6k_scinaiimmu.htm
2023-09-196-K2023-09-19REPORT OF FOREIGN PRIVATE ISSUERea185361-6k_scinaiimmu.htm
2023-09-116-K2023-09-11REPORT OF FOREIGN PRIVATE ISSUERea185004-6k_scinaiimmu.htm
2023-09-066-K2023-09-06REPORT OF FOREIGN PRIVATE ISSUERea184754-6k_scinaiimmu.htm
2023-09-066-K2023-09-06REPORT OF FOREIGN PRIVATE ISSUERea184755-6k_scinaiimmu.htm
2023-08-246-K2023-08-24REPORT OF FOREIGN PRIVATE ISSUERea184177-6k_biondvax.htm
2023-08-236-K2023-08-23REPORT OF FOREIGN PRIVATE ISSUERea184106-6k_biondvax.htm
2023-08-186-K/A2023-06-30AMENDMENT NO. 2 TO FORM 6-Kea183829-6ka2_biondvax.htm
2023-08-146-K/A2023-06-30AMENDMENT NO. 1 TO FORM 6-Kea183429-6ka1_biondvax.htm
2023-08-116-K2023-08-11REPORT OF FOREIGN PRIVATE ISSUERea183349-6k_biondvax.htm
2023-08-016-K2023-08-01CURRENT REPORTea182705-6k_biondvax.htm
2023-07-126-K2023-07-12REPORT OF FOREIGN PRIVATE ISSUERea181678-6k_biondvax.htm
2023-07-056-K2023-07-05REPORT OF FOREIGN PRIVATE ISSUERea181326-6k_biondvax.htm
2023-07-056-K2023-07-05REPORT OF FOREIGN PRIVATE ISSUERea181327-6k_biondvax.htm
2023-07-036-K2023-07-03REPORT OF FOREIGN PRIVATE ISSUERea181298-6k_biondvax.htm
2023-07-036-K2023-07-03REPORT OF FOREIGN PRIVATE ISSUERea181297-6k_biondvax.htm
2023-01-236-K2023-01-23REPORT OF FOREIGN PRIVATE ISSUERea172050-6k_biondvax.htm
2023-01-116-K2023-01-11REPORT OF FOREIGN PRIVATE ISSUERea171484-6k_biondvax.htm
2023-01-096-K2023-01-09REPORT OF FOREIGN PRIVATE ISSUERea171420-6k_biondvax.htm
2023-01-046-K2023-01-04REPORT OF FOREIGN PRIVATE ISSUERea171048-6k_biondvax.htm